Journal Overview
Aims & Scope
A dedicated home for research on cancer drug resistance.
Cancer Drug Resistance is an international Open Access journal dedicated to understanding and overcoming treatment resistance in cancer. We publish basic, translational, and clinical research on the mechanisms, evolution, biomarkers, and therapeutic strategies underlying or reversing resistance.
Key areas include: targeted therapies · immunotherapy · antibody–drug conjugates · radioligand therapy · cellular therapies · liquid biopsy · cancer evolution · emerging resistance mechanisms and therapeutic approaches.
Abstracting & Indexing
Indexed within ESCI (Web of Science), PubMed/PMC, Scopus, CAS, CNKI, Dimensions, Lens, Embase, ASCI
Rapid Publication
9 days — Time to First Decision, Within 3 days — Acceptance to Publication
Recognition of Reviewers
We recognize the contributions of our reviewers. Reviewers who provide timely, high-quality reports receive an APC discount voucher for a future publication in an OAE journal. Become a reviewer.
